Evidence and Resources

The best outcomes start with evidence. And when evidence underpins policies and programs and is shared across borders and sectors, it can drive radical progress. 

Explore the latest resources on multiple micronutrient supplements (MMS) research, policy, and implementation below. 

  • ImplementationManufacturersProduct Specifications

    UNIMMAP MMS Product Packaging Options, Cost, and Environmental Impact

    Kirk HumanitarianJanuary 2022

    Infographic presenting the financial and environmental implications and availability of MMS depending on common packaging options. 

  • Manufacturers

    Contract Pharmacal Corp (CPC)

    CPCSeptember 2019

    Contract pharmaceutical manufacturer and developer in the U.S. known to manufacture MMS.  

  • Manufacturers

    Lomapharm

    Lomapharm August 2019

    Contract pharmaceutical manufacturer and developer in Germany known to manufacture MMS.

After 20 years of research and some 20 studies and meta-analyses comparing IFA and MMS on birth outcomes, it is unethical to further withhold MMS from pregnant women in low-resource settings.”

Klaus Kraemer, PhD, Sight and Life 

Learn more about our work and impact.

Learn about recommended MMS technical specifications.